Background: Diet and smoking are the main sources of cadmium exposure in the general population. Cadmium increases the risk of cardiovascular diseases, and experimental studies show that it induces inflammation. Blood cadmium levels are associated with macrophages in human atherosclerotic plaques. Soluble urokinase-type plasminogen activator receptor (suPAR) is an emerging biomarker for cardiovascular events related to inflammation and atherosclerotic plaques. The aim was to examine whether blood cadmium levels are associated with circulating suPAR and other markers of inflammation. Methods: A population sample of 4648 Swedish middle-aged women and men was examined cross-sectionally in 1991-1994. Plasma suPAR was assessed by ELISA, leukocytes were measured by standard methods, and blood cadmium was analysed by inductively coupled plasma mass spectrometry. Prevalent cardiovascular disease, ultrasound-assessed carotid plaque occurrence, and several possible confounding factors were recorded. Results: After full adjustment for risk factors and confounding variables, a 3-fold increase in blood cadmium was associated with an 10.9% increase in suPAR concentration (p < 0.001). In never-smokers, a 3-fold increase in blood cadmium was associated with a 3.7% increase in suPAR concentration (p < 0.01) after full adjustment. Blood cadmium was not associated with C-reactive protein, white blood cell count and Lp-PLA2 but with neutrophil/lymphocyte ratio in one of two statistical models. Conclusions: Exposure to cadmium was associated with increased plasma suPAR in the general population, independently of smoking and cardiovascular disease. These results imply that cadmium is a possible cause for raised levels of this inflammatory marker.
Introduction
The general population is exposed to cadmium by consuming food items such as rice, wheat, vegetables, and potatoes; and, for those who smoke, by uptake of cadmium from tobacco smoke in the lungs (Nordberg et al., 2015) . Cadmium is mainly accumulated in the (Åkesson et al., 2014; Larsson et al., 2015) . An accumulating body of data shows that cadmium exposure is also associated with increased risk of atherosclerotic diseases such as myocardial infarction and stroke (Larsson et al., 2015) . The evidence is based on experimental (Subramanyam et al., 1992; Messner et al., 2009; Knoflach et al., 2011; Almenara et al., 2013) , cross-sectional, and prospective studies of clinical events (Tellez-Plaza et al., 2013; Barregard et al., 2016) , and on investigations of subclinical atherosclerosis in different vascular beds (Fagerberg et al., 2012 Bergström et al., 2015) .
There is an uptake of cadmium in many organs including liver, arterial vessel wall, and atherosclerotic plaques (Bergström et al., 2015; Vuori et al., 1979) . Many toxic mechanisms have been demonstrated, with the pro-inflammatory effects particularly in focus (Olszowski et al., 2012) . The majority of these studies, which have been performed in vitro and in vivo in different cell lines, in animal models, and in humans, suggest that cadmium causes up-regulation of the mediators and markers of inflammation (Olszowski et al., 2012) .
Inflammation is an important component of the atherosclerotic disease process (Packard and Libby, 2008) . Many circulating inflammatory biomarkers have been linked to cardiovascular diseases, although the underlying mechanisms are poorly known (Lubrano et al., 2015) . Serum C-reactive protein (CRP) and white blood cell count (WBC) are well-known such markers (Emerging Risk Factors Collaboration, Kaptoge et al., 2010; Madjid et al., 2004) . The ratio of the neutrophil to lymphocyte count may carry specific and strong information on future coronary risk (Fowler et al., 2013) . Lipoproteinassociated phospholipase A2 (Lp-PLA2), which is involved in the metabolism of oxidized low-density lipoprotein (LDL), is an established predictor of future cardiovascular disease (Maiolino et al., 2015) .
The urokinase-type plasminogen activator receptor (uPAR) is a membrane-bound protein that is highly expressed in macrophages and in symptomatic atherosclerotic plaques, and is locally enriched within symptomatic plaques (Svensson et al., 2004 (Svensson et al., , 2008 Steins et al., 2004) . Both uPAR and cadmium seem to accumulate in close connection to macrophages in symptomatic carotid plaques (Svensson et al., 2008; Fagerberg et al., 2016) . uPAR is associated with fibrinolysis, cell migration, and matrix degeneration (Hodges et al., 2015) . It is also released from the cell surface into blood in a soluble form (suPAR) and may reflect a pathophysiological pathway more closely linked with subclinical organ damage than CRP, which to a large extent mirrors obesity and dysmetabolism (Hodges et al., 2015) . suPAR levels reflect low-grade inflammation, and are associated with lifestyle factors such as smoking, alcohol intake, and sedentary lifestyle; in addition, women have higher levels than men (Hodges et al., 2015) . suPAR is a novel circulating biomarker, and may outperform traditional markers of inflammation such as CRP in prognosticating different cardiovascular diseases (Hodges et al., 2015; Persson et al., 2012 Persson et al., , 2014 . No previous studies have examined whether cadmium exposure is associated with suPAR.
Two population-based studies from National Health and Nutrition Examination Survey (NHANES) have shown associations between urinary cadmium levels and high-sensitivity CRP levels, and these associations also hold after adjustment for smoking (Lin et al., 2009; Colacino et al., 2014) and in never-smokers (Colacino et al., 2014) . However, one of these studies found a negative association between cadmium and WBC (Colacino et al., 2014) . In contrast, a previous in vivo study on rats demonstrated a potential positive association between acute cadmium exposure and increased WBC (Morgan et al., 1984) .
It is known that food items such as fibre and vegetables have the dual effects of both being important contributors to a high cadmium intake and conferring an anti-inflammatory effect (Nordberg et al., 2015) . This anti-inflammatory effect was suggested in the present cohort, in which a high intake of fibre, fruits, and vegetables was significantly correlated with lower CRP levels (Dias et al., 2015) . These data suggest that diet composition may reduce the pro-inflammatory effect of cadmium exposure; and, indeed, in NHANES a diet rich in anti-inflammatory nutrients was associated with a reduction in CRP (Colacino et al., 2014) .
We hypothesized that cadmium exposure is associated with an increase in circulating suPAR concentrations independently of known covariates related to sex, lifestyle, and anti-inflammatory nutrients. We also wanted to explore the associations between cadmium exposure, CRP, total WBC, the neutrophil to lymphocyte ratio, and Lp-PLA2.
Materials and methods
As previously described, all men and women in the city of Malmö, Sweden, born between 1923 and 1950 , were invited to participate in the Malmö Diet and Cancer Study (MDCS), which aimed to examine the association between dietary factors and cancer (Berglund et al., 1993) . Between 1991 and 1994, a random selection of half of those included in the MDCS and born between 1926 and 1945 were invited to a cardiovascular sub-study including ultrasound measurement of carotid atherosclerosis Hedblad et al., 2000) . Of the 6103 participants in the cardiovascular sub-cohort fasting blood samples were provided by 5540. The present study included participants with data available on cadmium in blood and circulating biomarkers of inflammation (n=4648). Reasons for exclusions were missing data on cadmium in blood (n=592), suPAR (n=204) CRP (n=134) and Lp-PLA2 activity (n=136). Mean age was identical between the total sub-cohort and the participants in the present study (57.5 years in both cases). Women constituted 60.0% and 59.2%, respectively, of these cohorts.
Cardiovascular risk factors
As previously reported the participants visited the study centre on three occasions Wirfält et al., 2001; Rosvall et al., 2005) . At the first visit the study questionnaires were distributed and the anthropometric measurements were performed. Non-fasting blood samples were taken, haematocrit, lymphocytes and neutrophils were analysed. Erythocytes were separated and stored in biobank. At the second visit trained interviewers conducted a diet history interview and checked the correctness of questionnaires. At the third visit fasting blood samples were drawn and stored in a biobank (Supplement).
Dietary habits were assessed by using a modified diet-history method, combining a 168-item quantitative diet history questionnaire, a 7 d menu book and a 1 h dietary interview (Wirfält et al., 2001; Dias et al., 2015) . Fibre and vegetable intake data were adjusted for total energy consumption (g/MJ). The diet data were in the regression analyses adjusted for season during year the examination was performed (see Supplement).
Participants were categorized into never-smokers, ex-smokers, and current smokers. Information on pack-years was available in 3707 subjects. . Daily alcohol intake was calculated.
Definitions of cardiovascular risk factors in the present study has been presented previously (Manjer et al., al., 2002; Rosvall et al., 2000) . Educational level was defined as the number of years of completed education. Low education included those who had < 9 years of education. A low leisure-time physical activity was defined as individuals belonging to the bottom quartile of the obtained physical activity score, modified from the Minnesota Leisure Time Activity Questionnaire. Alcohol intake was classified as high in women consuming > 30 g/day and in men with > 40 g/day. The self-administered questionnaire was used to acquire information on use of lipid-lowering, antihypertensive and antidiabetic drugs at baseline. Subjects were classified as having diabetes mellitus if they reported the diagnosis in the questionnaire, if they had a fasting venous whole blood glucose ≥6.1 mmol/L, or if they were taking medication for diabetes mellitus. Biochemical measurements of blood glucose, total cholesterol, highdensity lipoprotein (HDL) cholesterol, and triglycerides, as well as the calculation of LDL cholesterol, were performed according to usual practice .
Cardiovascular disease, subclinical atherosclerosis
Previous myocardial infarction and stroke were assessed by questionnaire and register data (Rosvall et al., 2005) . In connection with the first visit in the study, subjects underwent B-mode ultrasonography (Acuson128 CT system, Siemens, Mountain View, Ca, USA) of the right carotid artery, according to a standardized protocol, performed by trained, certified sonographers (Rosvall et al., 2000) . Atherosclerotic plaques were defined as a focal thickening of the intima-media complex > 1.2 mm and with an area ≥10 mm 2 . We have previously reported that blood cadmium levels are associated with the prevalence of carotid plaques after adjustment for cardiovascular risk factors .
Inflammatory biomarkers
WBC, neutrophil, and lymphocyte counts were measured at baseline. The biobank was used to measure CRP (2002), Lp-PLA2 activity (2005) , suPAR (2011) and cadmium (2012) (2013) . WBC, neutrophil, and lymphocyte counts (cells/L) were measured according to standard procedures at the Department of Clinical Chemistry, Skåne University Hospital, Malmö. CRP was analysed using a high-sensitivity assay, the Tina-quant® CRP latex assay (Roche Diagnostics, Basel, Switzerland), on an ADVIA® 1650 Chemistry System (Bayer Healthcare, NY; USA). Plasma levels of suPAR were measured in plasma drawn at baseline and stored at −80°C, using the commercial ELISA suPARnostic® kit (ViroGates, Copenhagen, Denmark). The inter-assay and intra-assay coefficients of variation were 9.2% and 2.1%, respectively. Lp-PLA2 activity (nmol/min/mL) was determined via a radiometric highthroughput activity assay.
Blood cadmium and lead concentrations
Cadmium is located in erythrocytes in blood, with a marginal concentration in plasma (Nordberg et al., 2015) . Cadmium was analysed in erythrocytes which had been stored at −80°C since baseline. Pipettes and vials used when obtaining erythrocytes from the biobank for the present study were carefully checked and found not to contribute to any contamination. The cadmium levels in the population were similar to those found in other studies of Swedish populations of the same age (Akesson et al., 2005) . Whole blood cadmium concentration was calculated from erythrocyte cadmium and haematocrit. The analysis was performed using inductively coupled plasma mass spectrometry (Agilent 7700x ICP-MS; Agilent Technologies, Sankta Clara, Ca, USA) operating in the helium collision cell mode, as described previously in detail . The imprecision (coefficient of variation) was 9.6%, as calculated for 50 duplicate samples. The limit of detection was 0.02 µg/L; no samples had levels below this. Analysis of external quality control samples and an interlaboratory comparison showed satisfactory results .
Lead concentration in erythrocytes were also analysed in parallel with the cadmium analysis and haematocrit was used to calculate blood lead concentrations as reported previously (Gambelunghe et al., 2016) .
Statistical analyses
Characteristics of the participants are shown by sex-specific quartiles of cadmium. Results are presented as means (standard deviation [SD] ) for continuous variables and as percentages for categorical variables. Blood cadmium, serum triglyceride and plasma glucose concentrations as well as all circulating inflammatory markers were skewed variables and are presented as median (25th, 75th percentiles) in Tables 1, 2 . Differences between groups were analysed with t-test, analysis of variance (ANOVA, trend) after log transformation of skewed variables (see above). Differences in proportions were analysed with a chi-squared test. Pearson's correlation coefficient was calculated.
The variables which were identified as potential confounders of associations between blood cadmium and inflammatory markers were sex, age, low education level, low level of physical activity, dietary intake of fibre and vegetables, smoking history, high alcohol intake, previous cardiovascular disease, body mass index (BMI), HDL cholesterol, triglycerides, and occurrence of carotid plaques as assessed by ultrasound (Tables 1-3) (Nordberg et al., 2015; Hodges et al., 2015; Persson et al., 2014; Fagerberg et al., 2015) . Interaction terms were introduced for blood cadmium and sex, as well as age. In sensitivity analyses the associations with blood lead levels, pack-years and time since smoking cessation were examined. The associations between smoking history as well as time since smoking cessation in ex-smokers and circulating markers of inflammation were also examined.
Linear regression analysis adjusting for the covariates listed above was used to analyse the associations between blood cadmium and circulating inflammatory biomarkers. Blood cadmium, triglycerides, and the inflammatory biomarkers were skewed, and hence were natural log (ln) transformed for the analyses. Firstly, estimates with 95% confidence intervals are presented as percentage change in inflammatory biomarkers for a threefold increase of blood cadmium. Secondly, an additional analysis was performed by analyzing changes in inflammatory markers by quartiles of blood cadmium after full adjustment for potential confounders. Dummy variables for cadmium quartiles 2, 3 and 4 were created and changes of biomarkers for each of these quartiles in relation to those in quartile 1 were calculated as well as 95% confidence intervals. These two analyses were conducted both in the entire study group and in the never smoking group. Significance tests were two-sided, and p < 0.05 was considered statistically significant. All analyses were performed using version 20 of the SPSS software package (IBM Corp.).
Results
Characteristics of the participants are shown in Table 1 . On average, blood cadmium concentrations were slightly higher in women than in men (p < 0.001). Increasing quartiles of blood cadmium were associated with low BMI, low educational level, low degree of physical activity, and low intake of fibre and vegetables. High blood cadmium levels were associated with current and previous smoking, higher alcohol intake, blood lead and serum triglycerides as well as higher prevalences of carotid plaques and previous cardiovascular disease. Elevated cadmium concentrations were associated with low serum HDL cholesterol. Circulating concentrations of suPAR, CRP, WBC, neutrophil/lymphocyte ratio, and Lp-PLA2 activity were positively associated with blood cadmium (Table 2 ). Blood lead showed statistically significant correlation with blood cadmium (r=0.24, p < 0.001), WBC (r=0.066, p < 0.001) and Lp-PLA2 Activity (r=0.056, p < 0.001) but not with suPAR, CRP, or neuthrophil/lymphocyte ratio (Supplement).
All inflammatory biomarkers showed significant positive correlations with BMI and glucose and negative correlations with HDL cholesterol, with the exception of neutrophil/lymphocyte ratio (Table 3) . LDL cholesterol was strongly positively correlated with Lp-PLA2 activity, and negatively correlated with neutrophil/lymphocyte ratio. With the exception of neutrophil/lymphocyte ratio, all biomarkers were positively correlated with triglycerides. All inflammatory biomarkers showed negative correlations with dietary intake of fibre and vegetables, respectively.
As shown in Table 4 , the levels of all inflammatory markers were increased in current smokers compared with those in never-smokers. The CRP and WBC levels in previous smokers were significantly higher than those in never-smokers.
The mean time since smoking cessation in previous smokers was 18 years, ranging from 1-53 years. As presented in Supplemental Table S2 CRP and WBC gradually decreased over time since smoking cessation (p < 0.001 for both), whereas no corresponding change were observed in the remaining inflammatory markers.
Multivariable analyses were performed, with adjustment for sex and age in the first step and for covariates associated with both blood cadmium and inflammatory biomarkers in the second step. The results showed that elevation of blood cadmium was associated with increases in all inflammatory biomarkers (Table 5 ). In subsequent similar analyses that only included never-smokers, similar findings were only obtained with suPAR and neutrophil/lymphocyte ratio (Table 6) . Hence, in all participants, irrespective of smoking history, a 3-fold increase in blood cadmium was associated with a 10.9% (p < 0.001) increase in suPAR concentration after full adjustment and a 5.0% (p < 0.001) increase in neutrophil/lymphocyte ratio. In never-smokers, a 3-fold increase in blood cadmium was associated with a 3.7% (p < 0.01) increase in suPAR concentration after full adjustment and a 4.6% (p < 0.05) increase in neutrophil/lymphocyte ratio.
In a sensitivity analysis with adjustment for blood lead concentrations and also pack-years in a subgroup of participants with such data available there was no principal change of the results (Supplemental Table S3 ). Similar results were also obtained with further adjustment for time since smoking cessation (Table S3 ). Addition of ln-transformed CRP to the linear regressions did not change the results (data not shown). A multivariable regression analysis including potential confounders did not show any statistically significant interactions between blood cadmium and sex or between blood cadmium and age, neither in the total study group, nor in the never-smoking (Supplemental Table S4 ).
In the additional, alternative statistical model with analyses of changes in inflammatory markers by quartiles of blood cadmium the results were similar to those obtained as by the first model (Supplemental Tables S5, S6 ). The exception was the neutrophil/ lymphocyte ratio that did not show statistically significant change between blood cadmium quartiles in never smokers.
Discussion
In the present study, we found that blood cadmium concentrations were associated with circulating suPAR levels after adjustment for all potential confounders. These relationships were also found in the subgroup of never-smokers.
A seemingly contradictory finding is the negative association between blood cadmium and the intake of fibre and vegetables, which are the main sources of high cadmium dietary consumption (Nordberg et al., 2015) . This is explained by the confounding effect of smoking as the major source of high exposure to cadmium in general populations. In the group of never smokers, there was a positive association between cadmium and intake of dietary fibres and vegetables (see Supplemental  Table S1 ).
Smoking is a major confounder; it is closely associated both with cadmium levels and with the inflammatory biomarkers, which were increased in current smokers compared with never-smokers. This finding might be explained by a pro-inflammatory effect of tobacco smoke (Csordas et al., 2013) . We tried to clarify this issue with a crosssectional analysis of the association between time since smoking cessation and levels of inflammatory markers. The results clearly indicated that CRP concentration and WBC count decreased very slowly over time, and after several decades reached similar levels to those in never-smokers. These data support the notion that tobacco smoke has proinflammatory effects on these biomarkers which wane (9) 116 (10) 103 (9) 101 (9) 96 (8) over time after smoking cessation. In a previous study, CRP gradually decreased over 40 years following smoking cessation, but the conclusion was that the lifetime exposure to smoking was even more important (Tracy et al., 1997 ). An alternative explanation might be that tobacco smoking is a strong pro-atherosclerotic factor, and that atherosclerotic disease per se is associated with inflammation (Colacino et al., 2014) . We performed multivariable linear regression analyses adjusted for potential confounding factors for cadmium and inflammation, including smoking history with participants classified as never-smokers, exsmokers, and current smokers. In these analyses, all inflammatory markers remained significantly associated with blood cadmium. However, residual confounding by smoking could not be excluded, and so we performed subgroup analyses in never-smokers, demonstrating that only suPAR and neutrophil/lymphocyte ratios were independently associated with blood cadmium. Neither CRP, WBC, nor Lp-PLA2 showed any association with blood cadmium in neversmokers. As mentioned above, a previous NHANES study found a positive association between urinary cadmium and CRP in neversmokers, as well as a negative association with WBC (Colacino et al., 2014) .
Our finding that suPAR was independently associated with blood cadmium supports our hypothesis and raises the question whether elevated suPAR may be explained by underlying atherosclerotic disease. Firstly, it has been shown in the present cohort that serum suPAR predicts cardiovascular disease and subclinical carotid atherosclerosis (Persson et al., , 2014 . In comparison with CRP, the serum levels of suPAR are more strongly related both to carotid plaques as assessed by ultrasound, and to coronary atherosclerosis as measured with calcium score (Lyngbaek et al., 2013; Sørensen et al., 2014) . Secondly, both cadmium and suPAR co-vary with the accumulation of macrophages in carotid plaques, and cadmium has proinflammatory effects (Bergström et al., 2015; Olszowski et al., 2012; Svensson et al., 2004 Svensson et al., , 2008 Fagerberg et al., 2016; Edsfeldt et al., 2012) . However, the association between cadmium and suPAR remained after inclusion of clinical cardiovascular disease and subclinical carotid atherosclerosis as covariates in the analysis. Hence, there is no clear indication that the association between cadmium exposure and suPAR is mediated through enhanced atherosclerosis. Another unresolved question is that of whether cadmium may contribute to increased vulnerability, including inflammation, in atherosclerotic plaque (Bergström et al., 2015; Edsfeldt et al., 2012) . It is known that conditions with increased inflammatory activity lead to an augmented atherosclerotic disease process (John et al., 2012) . suPAR is associated with low-grade inflammation, and is also elevated in rheumatoid arthritis and other conditions (Slot et al., 1999; Eugen-Olsen et al., 2010) . Many experimental studies have shown that cadmium has proinflammatory effects (Olszowski et al., 2012) . Tentatively cadmium may contribute to a general low level of inflammation, reflected by suPAR, which can have pro-atherosclerotic effects.
We also observed in never smokers that the neutrophil/lymphocyte ratio was independently associated with blood cadmium in one of the two statistical models. As we could not replicate the observation in the second statistical model our interpretation is that we still lack evidence that neutrophil/lymphocyte ratio is associated with cadmium exposure. This ratio non-specifically reflects the severity of diseases with an inflammatory component, including cardiovascular diseases, different cancers, and mortality risk (Fowler et al., 2013; Balta et al., 2016) .
Apart from cadmium, also exposure to other metals such as lead, arsenic and mercury has been linked to increased cardiovascular risk and often inflammation (Aoki et al., 2016; Sidhu et al., 2015; Houston, 2011) . We found that blood lead concentrations correlated positively with WBC and LpPLA2 Activity in univariate analysis. However, blood lead did not confound the associations between blood cadmium and inflammatory markers in multivariable analyses. Previously reported NHANES data failed to show associations between blood lead concentrations and CRP, WBC and fibrinogen (Songdej et al., 2010) . A limitation of the present study is that we had no data on arsenic or mercury exposure.
A further limitation of the present study is that its cross-sectional design meant we could not elicit any information on causal effects. In addition, although smoking is a key factor, we had no objective measures of smoking history and insufficient information on lifetime burden of smoking, and had to rely on self-reported data.
Conclusions
In conclusion, we consider our results to provide robust evidence within our study population that cadmium exposure is associated with increased levels of suPAR. We found no support for a major mediating effect by underlying atherosclerotic disease, and suggest that the underlying mechanism is most likely a pro-inflammatory effect of cadmium. Although the results have to be corroborated by other studies, the size and quality of the present study justify the conclusion that cadmium could be a cause for raised levels of these inflammatory markers.
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